Delivery Order SPE2DR25D2206-SPE2DR26F0BPN
Award Date 4/22/26
Potential Completion Date 5/13/26
Potential Value $20K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 24, 2026, for $21,516.67 to supply Mekinist 2 mg tablets (30-count units) under a firm fixed-price structure with an ultimate completion date of May 15, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier delivering brand-name and generic medications,...
- The Defense Logistics Agency awarded a $21,516.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Mekinist 2 mg tablets (quantity: 30 units). This non-set-aside contract is scheduled for completion by February 11, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,516.67 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on January 15, 2026, with completion scheduled for February 6, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $40,764.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where the contractor maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,390.46 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) with a completion date of February 9, 2026. The contract was awarded on January 16, 2026, using firm fixed-price pricing with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, with a ceiling value of $11,195.23 for supply of Mekinist 2 mg tablets (30-count unit of use packaging). Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 23, 2026. No set-aside was used. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a Delivery Order valued at $11,195.23 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Mekinist 2 mg tablets in quantities of 30. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by February 3, 2026. The awardee, based in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,195.23 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of February 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency issued a $11,195.23 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for Mekinist 2 mg tablets (30-count unit of use packaging). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a single-award IDC valued at up to $999,999,999 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F0BPNDelivery Order
The Defense Logistics Agency issued a $19,769.64 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Mekinist 0.5 mg tablets (30-count). Place of performance is Conshohocken, PA. Ultimate completion date is May 13, 2026. The order is priced firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal healthcare systems. The company holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 7/21/26, 9:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 4/21/26 |